<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The management of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> continues to challenge clinical investigators </plain></SENT>
<SENT sid="1" pm="."><plain>With bone marrow transplantation or immunosuppression the prognosis of the patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> has improved remarkably </plain></SENT>
<SENT sid="2" pm="."><plain>For patients who are not eligible for bone marrow transplantation, antilymphocyte globulin has become the standard treatment </plain></SENT>
<SENT sid="3" pm="."><plain>There is growing evidence that some patients also respond to immunosuppression with <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Further data suggest that combination of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> with antilymphocyte globulin or <z:chebi fb="5" ids="50113">androgens</z:chebi> might be beneficial </plain></SENT>
<SENT sid="5" pm="."><plain>An international workshop summarized the data on <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> treatment in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and attempted to create guidelines for the use of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> in the management of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>